Lifecore Biomedical, Inc.LFCRNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.75% | +8.01% | -1.54% | -3.81% | +25.92% |
| Gross Profit Growth | +97.47% | +11.32% | -17.23% | -19.05% | +44.63% |
| EBITDA Growth | +0.00% | -95.10% | -133.90% | +603.11% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +147.88% | +0.00% |
| Net Income Growth | +0.00% | -146.22% | -194.48% | +0.00% | +0.00% |
| EPS Growth | +0.00% | -153.19% | -192.16% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | -164.10% | -209.30% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.49% | +12.81% | +21.43% | +21.15% | +21.22% |
| Weighted Average Shares Diluted Growth | +1.49% | -5.65% | +1.12% | +21.15% | +21.22% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -574.38% | +0.00% | -38.11% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | -45.86% | +0.00% |
| Receivables Growth | -5.53% | -33.19% | -38.42% | +40.17% | +15.86% |
| Inventory Growth | -0.12% | -5.39% | -12.79% | -19.23% | -18.83% |
| Asset Growth | +0.49% | +3.89% | -3.47% | -5.76% | -4.71% |
| Book Value per Share Growth | +0.00% | -67.66% | -89.62% | -90.25% | +0.00% |
| Debt Growth | +15.41% | +9.21% | +3.22% | -2.06% | +0.49% |
| R&D Expense Growth | +1.86% | -8.29% | -5.76% | -2.68% | -10.20% |
| SG&A Expenses Growth | +55.36% | +19.02% | +2.49% | -26.54% | -37.81% |